These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 16005579

  • 1. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
    Gál K, Gyertyán I.
    Drug Alcohol Depend; 2006 Jan 04; 81(1):63-70. PubMed ID: 16005579
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G, Butini S, Trotta F, Fattorusso C, Catalanotti B, Aiello F, Gemma S, Nacci V, Novellino E, Stark JA, Cagnotto A, Fumagalli E, Carnovali F, Cervo L, Mennini T.
    J Med Chem; 2003 Aug 28; 46(18):3822-39. PubMed ID: 12930145
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
    Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD.
    J Pharmacol Exp Ther; 2000 Aug 13; 294(2):680-7. PubMed ID: 10900248
    [Abstract] [Full Text] [Related]

  • 7. Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats.
    Alleweireldt AT, Weber SM, Kirschner KF, Bullock BL, Neisewander JL.
    Psychopharmacology (Berl); 2002 Jan 13; 159(3):284-93. PubMed ID: 11862361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Disruption of nicotine conditioning by dopamine D(3) receptor ligands.
    Le Foll B, Schwartz JC, Sokoloff P.
    Mol Psychiatry; 2003 Feb 13; 8(2):225-30. PubMed ID: 12610655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.
    Di Clemente A, Franchi C, Orrù A, Arnt J, Cervo L.
    Addict Biol; 2012 Mar 13; 17(2):274-86. PubMed ID: 21521422
    [Abstract] [Full Text] [Related]

  • 16. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.
    Banasikowski TJ, Bespalov A, Drescher K, Behl B, Unger L, Haupt A, Schoemaker H, Sullivan JP, Gross G, Beninger RJ.
    J Pharmacol Exp Ther; 2010 Nov 13; 335(2):506-15. PubMed ID: 20724485
    [Abstract] [Full Text] [Related]

  • 17. Effect of schedule of reinforcement on cue-elicited reinstatement of cocaine-seeking behavior.
    Acosta JI, Thiel KJ, Sanabria F, Browning JR, Neisewander JL.
    Behav Pharmacol; 2008 Mar 13; 19(2):129-36. PubMed ID: 18332677
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR, Gitajn L, Gardner EL.
    Neuropsychopharmacology; 2006 Jul 13; 31(7):1393-405. PubMed ID: 16205781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.